These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 9229305)
1. Pulmonary hypertension in severe congestive heart failure: how important is it? Hunt SA J Heart Lung Transplant; 1997 Jun; 16(6):S13-5. PubMed ID: 9229305 [No Abstract] [Full Text] [Related]
2. Regression of "fixed" pulmonary vascular resistance in heart transplant candidates after unloading with ventricular assist devices. Beyersdorf F; Schlensak C; Berchtold-Herz M; Trummer G J Thorac Cardiovasc Surg; 2010 Oct; 140(4):747-9. PubMed ID: 20850652 [No Abstract] [Full Text] [Related]
3. Left ventricular assist device or heart transplantation: impact of transpulmonary gradient and pulmonary vascular resistance on decision making. Mikus E; Stepanenko A; Krabatsch T; Dandel M; Lehmkuhl HB; Loforte A; Hetzer R; Potapov EV Eur J Cardiothorac Surg; 2011 Mar; 39(3):310-6. PubMed ID: 20615720 [TBL] [Abstract][Full Text] [Related]
4. Is fixed severe pulmonary hypertension still a contraindication to heart transplant in the modern era of mechanical circulatory support? A review. Andrea G; Giuseppe B; Tiziano C; Maria F; Ettore V J Cardiovasc Med (Hagerstown); 2008 Oct; 9(10):1059-62. PubMed ID: 18799971 [TBL] [Abstract][Full Text] [Related]
5. Normalization of high pulmonary vascular resistance with LVAD support in heart transplantation candidates. Salzberg SP; Lachat ML; von Harbou K; Zünd G; Turina MI Eur J Cardiothorac Surg; 2005 Feb; 27(2):222-5. PubMed ID: 15691674 [TBL] [Abstract][Full Text] [Related]
6. Acute hemodynamic effects of intravenous sildenafil citrate in congestive heart failure: comparison of phosphodiesterase type-3 and -5 inhibition. Botha P; Parry G; Dark JH; Macgowan GA J Heart Lung Transplant; 2009 Jul; 28(7):676-82. PubMed ID: 19560695 [TBL] [Abstract][Full Text] [Related]
7. Left ventricular assist device support of medically unresponsive pulmonary hypertension and aortic insufficiency. Adamson RM; Dembitsky WP; Jaski BE; Daily PO; Moreno R; Kim JC; Sono J; Akasaka T; Hoagland PM; Gordon JB ASAIO J; 1997; 43(4):365-9. PubMed ID: 9242955 [TBL] [Abstract][Full Text] [Related]
8. Does pretransplant left ventricular assist device therapy improve results after heart transplantation in patients with elevated pulmonary vascular resistance? Liden H; Haraldsson A; Ricksten SE; Kjellman U; Wiklund L Eur J Cardiothorac Surg; 2009 Jun; 35(6):1029-34; discussion 1034-5. PubMed ID: 19211259 [TBL] [Abstract][Full Text] [Related]
9. Implantable left ventricular assist device for treatment of pulmonary hypertension in candidates for orthotopic heart transplantation-a preliminary study. Martin J; Siegenthaler MP; Friesewinkel O; Fader T; van de Loo A; Trummer G; Berchtold-Herz M; Beyersdorf F Eur J Cardiothorac Surg; 2004 Jun; 25(6):971-7. PubMed ID: 15144997 [TBL] [Abstract][Full Text] [Related]
10. Acute right ventricular failure following heart transplantation: improvement with prostaglandin E1 and right ventricular assist. Fonger JD; Borkon AM; Baumgartner WA; Achuff SC; Augustine S; Reitz BA J Heart Transplant; 1986; 5(4):317-21. PubMed ID: 3305824 [TBL] [Abstract][Full Text] [Related]
11. Response of the right ventricle to acute pulmonary vasodilation predicts the outcome in patients with advanced heart failure and pulmonary hypertension. Gavazzi A; Ghio S; Scelsi L; Campana C; Klersy C; Serio A; Raineri C; Tavazzi L Am Heart J; 2003 Feb; 145(2):310-6. PubMed ID: 12595849 [TBL] [Abstract][Full Text] [Related]
12. Prostaglandin E1 testing in heart failure-associated pulmonary hypertension enables transplantation: the PROPHET study. von Scheidt W; Costard-Jaeckle A; Stempfle HU; Deng MC; Schwaab B; Haaff B; Naegele H; Mohacsi P; Trautnitz M; J Heart Lung Transplant; 2006 Sep; 25(9):1070-6. PubMed ID: 16962468 [TBL] [Abstract][Full Text] [Related]
17. Hemodynamic and inotropic effects of milrinone after heart transplantation in the setting of recipient pulmonary hypertension. Chen EP; Bittner HB; Davis RD; Van Trigt P J Heart Lung Transplant; 1998 Jul; 17(7):669-78. PubMed ID: 9703231 [TBL] [Abstract][Full Text] [Related]
18. Left ventricular assist devices decrease fixed pulmonary hypertension in cardiac transplant candidates. Zimpfer D; Zrunek P; Roethy W; Czerny M; Schima H; Huber L; Grimm M; Rajek A; Wolner E; Wieselthaler G J Thorac Cardiovasc Surg; 2007 Mar; 133(3):689-95. PubMed ID: 17320566 [TBL] [Abstract][Full Text] [Related]
19. Early increase in pulmonary vascular reactivity with overexpression of endothelin-1 and vascular endothelial growth factor in canine experimental heart failure. Ray L; Mathieu M; Jespers P; Hadad I; Mahmoudabady M; Pensis A; Motte S; Peters IR; Naeije R; McEntee K Exp Physiol; 2008 Mar; 93(3):434-42. PubMed ID: 17993509 [TBL] [Abstract][Full Text] [Related]
20. Resolution of severe pulmonary hypertension after heterotopic cardiac transplantation. Villanueva FS; Murali S; Uretsky BF; Reddy PS; Griffith BP; Hardesty RL; Kormos RL J Am Coll Cardiol; 1989 Nov; 14(5):1239-43. PubMed ID: 2808977 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]